Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study

Self Cite

Section: Methodsmentioning

confidence: 99%

“…PROMIS measures have undergone rigorous evaluation, including validation in men with prostate cancer. [18][19][20][21] PROMIS scores are normed to the US general population at a mean of 50 and a standard deviation of 10. Higher symptom scores reflect increased symptom burden, and higher function scores reflect better functioning.…”

Section: Data and Measuresmentioning

confidence: 99%

Symptom and function profiles of men with localized prostate cancer

Reeve

Tan

Chen

et al. 2018

Self Cite

“…However, the current analyses may not be able to be replicated among samples of patients with prostate cancer who have much less anxiety. 49 Our linking tables should be used with the knowledge that concordance between the scores of any 2 instruments may be sensitive to population differences, regardless of the linking method. 34 However, the results of a recent study have suggested that these population differences can be minor; we found that the linking relationships for PROMIS Pain Interference and the Brief Pain Inventory were very similar when obtained from the general population versus patients with multiple sclerosis.…”

Section: Discussionmentioning

confidence: 99%

Establishing a common metric for self‐reported anxiety in patients with prostate cancer: Linking the Memorial Anxiety Scale for Prostate Cancer with PROMIS Anxiety

Victorson

Schalet

Kundu

et al. 2019

BACKGROUND: Anxiety is a common patient concern and clinical endpoint in prostate cancer outcomes research. It is measured using different self-report instruments that are not directly comparable, thereby making clinical trials, clinical performance measurement, and comparative effectiveness research challenging when anxiety is the outcome of interest. The objective of the current study was to enable a common reporting metric of anxiety so that scores on commonly used anxiety measures could be converted into Patient-Reported Outcomes Measurement Information System (PROMIS) scores for ease of application, interpretation, and comparability. METHODS: Using an internet health panel, a total of 806 men with clinically localized prostate cancer completed items from the National Institutes of Health PROMIS Anxiety Short Form (version 7a) and the 18-item Memorial Anxiety Scale for Prostate Cancer (MAX-PC). A common metric was created using analyses based on item response theory, producing score crosswalk tables. The linking relationships were evaluated by resampling small subsets and estimating confidence intervals for the differences between the observed and linked PROMIS scores. RESULTS: Results of factor analysis and item response theory model fit supported the hypothesis that both scales measure essentially the same concept. Therefore, crosswalk tables appear to be justified and increasingly robust with increasing sample sizes. CONCLUSIONS: MAX-PC Anxiety results can be expressed on the PROMIS Anxiety metric for the purposes of clinical performance measurement, clinical trial outcomes, comparative effectiveness research, and other efforts to compare anxiety results across studies that use any one of these measures. Cancer 2019;125:3249-3258.

“…Patient‐reported anxiety and depression are measured with the Patient‐Reported Outcomes Measurement Information System (PROMIS) scale, which has been validated for use in the general population as well as adults diagnosed with chronic conditions, including cancer . A higher PROMIS score indicates greater anxiety/depression.…”

Section: Methodsmentioning

confidence: 99%

Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study

Beebe‐Dimmer

Ruterbusch

Harper

et al. 2020

Background The benefit of regular exercise in improving cancer outcomes is well established. The American Cancer Society (ACS) released a recommendation that cancer survivors should engage in at least 150 minutes of moderate to vigorous physical activity (PA) per week; however, few report meeting this recommendation. This study examined the patterns and correlates of meeting ACS PA recommendations in the Detroit Research on Cancer Survivors (ROCS) cohort of African American cancer survivors. Methods Detroit ROCS participants completed baseline and yearly follow‐up surveys to update their health and health behaviors, including PA. This study examined participation in PA by select characteristics and reported health‐related quality of life (HRQOL) as measured with the Functional Assessment of Cancer Therapy and Patient‐Reported Outcomes Measurement Information System instruments. Results Among the first 1500 ROCS participants, 60% reported participating in regular PA, with 24% reporting ≥150 min/wk. Although there were no differences by sex, prostate cancer survivors were the most likely to report participating in regular PA, whereas lung cancer survivors were the least likely (P = .022). Survivors who reported participating in regular PA reported higher HRQOL (P < .001) and lower depression (P = .040). Conclusions Just 24% of African American cancer survivors reported meeting the ACS guidelines for PA at the baseline, but it was encouraging to see increases in activity over time. Because of the established benefits of regular exercise observed in this study and others, identifying and reducing barriers to regular PA among African American cancer survivors are critical for improving outcomes and minimizing disparities.